CAPA for Biopharmaceutical Manufacturers: Key Considerations
CAPA for Biopharmaceutical Manufacturers: Key Considerations Key Considerations for Implementing CAPA in Biopharmaceutical Manufacturing Introduction Corrective and Preventive Action (CAPA) is essential in the biopharmaceutical industry, where strict regulatory requirements and complex processes demand meticulous quality control. Unlike traditional pharmaceutical manufacturing, biopharmaceutical production involves living systems, which introduce unique challenges. This article explores the key…
Read More “CAPA for Biopharmaceutical Manufacturers: Key Considerations” »